Home › Markets › Health Care › ACTU

Actuate Therapeutics Inc. (ACTU)

ACTU trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · October 14, 2026
$0.4663
-27.56% on the day
Market cap
$11.2M
Nano cap
Revenue
Not reported in SEC XBRL data
Net income
Not reported in SEC XBRL data

Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.

Profile

FieldValue
TickerACTU on Nasdaq
SectorHealth Care
IndustryBiotechnology: Pharmaceutical Preparations
CountryUnited States
IPO year2024
SEC CIK0001652935
SEC industry codePharmaceutical Preparations
Incorporated inDE

Financials

Not reported in SEC XBRL data.

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document
FORM S-1 AMENDMENT
S-1/A2026-10-14
Latest annual report
FORM 10-K FOR DEC 2025
10-K2026-03-26
Latest quarterly / interim
FORM 10-Q FOR JUN 2026
10-Q2026-08-14
Latest current report
CURRENT REPORT
8-K2026-07-17
Latest proxy
ADDITIONAL DEFINITIVE PROXY SOLICITING MATERIALS
DEFA14A2026-05-06

Source: SEC EDGAR submissions feed, 182 recent filings. All filings on EDGAR.

Peers in Biotechnology: Pharmaceutical Preparations

TickerCompanyPriceDayMarket cap
ENSCEnsysce Biosciences Inc.$0.5725+2.99%$11.1M
TPSTTempest Therapeutics Inc.$0.6813-8.27%$11.3M
AEONAEON Biopharma Inc.$0.2297-6.47%$11.5M
ASBPAspire-Lakewood Holdings Inc.$8.18+5.14%$11.5M
KPRXKiora Pharmaceuticals Inc.$2.47-3.52%$10.9M
PHIOPhio Pharmaceuticals Corp.$0.9345+1.36%$10.9M
BLRXBioLineRx Ltd.$2.170.00%$10.8M
LSTALisata Therapeutics Inc.$1.08+2.86%$11.7M

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier